Tag Archives: Leukemia

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Pediatric leukemia 'super drug' could be developed in the coming years

Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years in the journal Cell, and the final paper published Dec. 20 in Genes & Development. When a key protein responsible for leukemia, MLL, is stabilized, it slows the… Read More »

Hairy Cell Leukemia (Advances in Blood Disorders)

Hairy cell leukemia has been the subject of much debate during the past forty years. The etiology and pathogenesis of the disease is still unclear, and the origin of the unusual “hairy” B-lymphocyte is still to be clarified with certainty. Nevertheless, clinical advances in the therapy of this disease have resulted in the control and… Read More »